In fiscal year 2025, DuChemBio (176750) reported revenue of 38.6 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 38.6 billion KRW | 7.4 billion KRW | 6.5 billion KRW | [source] |
| 2024 | 35.6 billion KRW | 5.1 billion KRW | 8.0 billion KRW | [source] |
| 2023 | 34.7 billion KRW | 5.3 billion KRW | 4.0 billion KRW | — |
| 2022 | 32.4 billion KRW | 1.6 billion KRW | -2.8 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 77.0 billion KRW | 28.4 billion KRW | 48.5 billion KRW | [source] |
| 2024 | 64.3 billion KRW | 22.2 billion KRW | 42.2 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2025 | — | — | -4.4 billion KRW | [source] |
| 2024 | — | — | 3.5 billion KRW | [source] |
| 2023 | — | — | — | — |
| 2022 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.
Cash flow figures for the relevant year were not collected.